Scripps 36th Annual New Treatments In Chronic Liver Disease 2022

Scripps 36th Annual New Treatments In Chronic Liver Disease 2022

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives
After attending this live activity, participants should be able to:

• • Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease.
• • Review vascular disorders and coagulation management principles for patients with chronic liver disease.
• • Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL).
• • Evaluate drugs in development for PBC and PSC.
• • Employ strategies for treating and managing ascites and hepatorenal syndrome.
• • Describe advances in HCC therapy and management of acute-on-chronic liver disease.

Target Audience

• Hepatologists
• • Gastroenterologists
• • Infectious Disease Specialist

Topics:

• ACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD
  Acute-on-Chronic Liver Disease – Timothy Morgan, MD
  Advanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD
  Advances in HCC – Catherine Frenette, MD
  AGA Guidelines for NAFLD – Mazen Noureddin, MD
  Autoimmune Hepatitis – John Vierling, MD
  Debate- Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD
  EASL Guidelines for Non-Invasive Testing – Michael Charlton, MD
  Panel Discussion1
  Panel Discussion2
  Panel Discussion3
  Reproductive Health and Chronic Liver Disease – Norah Terrault, MD
  Update on Management of Ascites and HRS – Florence Wong, MD
  Vascular Disorders and Anticoagulation – Patrick Northup, MD
  Viral Hepatitis B and C – Julio Gutierrez, MD
  When to Refer for Liver Transplantation – Adam Deising, MD
  WILLIAM S. HAUBRICH LECTURE- What’s New in PBC and PSC- – Kris Kowdley, MD